Medical Dermatology
Facing the world is not always easy for patients suffering from serious skin disorders. Dedicated to meeting the needs of these patients and their physicians, Allergan has developed some of the most technologically advanced dermatology products to treat skin disease as well as enhance the appearance of healthy skin.
According to the National Institutes of Health, between 5.8 and 7.5 million American suffer from psoriasis1, which is a chronic skin disorder than can take many different forms. An estimated 80 percent of all people between the ages of 11 and 30 have acne outbreaks at some point.2 Our dermatology portfolio includes TAZORAC® (tazarotene), the first topical receptor selective retinoid approved for psoriasis and acne.
Another common chronic condition affecting an estimated 7.8 million Americans is hyperhidrosis, which is the term for excessive sweating.3 Patients with hyperhidrosis produce an amount of sweat that far exceeds that needed to regulate body temperature. Our medical dermatology portfolio includes BOTOX® (Botulinum Toxin Type A) for severe primary axillary hyperhidrosis (excessive underarm sweating) that is not adequately managed by topical agents. As we look to the future in medical dermatology, Allergan will build upon the approved use of BOTOX® to treat excessive underarm sweating inadequately managed by topical agentsand has already initiated clinical trials to investigate the use of BOTOX® to treat excessive sweating of the hands or palms.